Brazil’s journey into cannabidiol regulation and commercialization has been shaped by complex legal reforms, scientific advocacy, and growing consumer demand for alternative therapies. Although cannabis was strictly prohibited for decades, pressure from patient associations and legal actions helped pave the way for controlled medical access. In 2015, Anvisa, Brazil’s national health surveillance agency, authorized the import of CBD products for individual use through prescription, initially for epilepsy treatment. The turning point came in 2019 when Anvisa approved the sale of CBD-based medicines in pharmacies under RDC 327, while still prohibiting domestic cultivation of cannabis. Early commercial imports were driven by international companies such as GW Pharmaceuticals with Epidiolex, which opened the door for a growing presence of isolate-based formulations. Brazil continues to limit full-spectrum options due to strict THC content regulations, leading companies to favor isolate extractions using CO2 and ethanol-based methods, refined by local players like Entourage Phytolab.

While CBD in food remains prohibited, research institutions such as Fiocruz have begun evaluating broader applications of cannabinoids, including their potential in dietary supplements pending regulatory updates. Advances in packaging and delivery have included child-resistant droppers and QR code-integrated labeling to ensure product traceability and transparency. Third-party testing is handled by certified labs such as Analítica Alfa, contributing to safety assurance for physicians and patients alike. Despite international legalization momentum, Brazil remains cautious, largely influenced by legal hurdles stemming from its alignment with the UN 1961 Convention and slow legislative progress in Congress. Companies face delays in product approvals, and gaps in local production capabilities limit supply chain efficiency. Meanwhile, public hospitals like Hospital das Clínicas in São Paulo have engaged in clinical trials studying long-term impacts of CBD for Parkinson’s and anxiety, pushing scientific validation forward. According to the research report, "Brazil Cannabidiol Market Research Report, 2030," published by Actual Market Research, the Brazil Cannabidiol market is anticipated to grow at more than 15.85% CAGR from 2025 to 2030.The competitive landscape in Brazil’s cannabidiol sector is evolving rapidly as domestic and international companies compete for pharmacy shelf space and e-commerce dominance.

Companies such as Prati-Donaduzzi and Verdemed have secured authorizations from Anvisa to sell pharmaceutical-grade CBD oils, while startups like Cantera and Health Meds focus on prescription-based imports. Online distribution is rising, particularly through specialized portals like Cannect and VerdeMed’s digital platforms, as Amazon and other large-scale retailers remain excluded due to regulatory limitations. Pharmacies including Drogasil and Pague Menos are increasingly integrating CBD into their chronic pain and wellness categories, although only under medical supervision. Multi-channel strategies are being adopted where licensed providers offer both in-store education and virtual consultations to guide consumers through complex prescription processes. Advertisement restrictions enforced by Anvisa prohibit mass marketing, prompting firms to focus on direct physician outreach and patient testimonials. Supply chain issues persist due to Brazil’s ban on cannabis cultivation, creating a reliance on imported active pharmaceutical ingredients, particularly from Canada and Colombia, where companies like Clever Leaves are active suppliers.

With increasing product availability, market saturation risks have emerged, leading players to differentiate through bioavailability enhancements using nanoemulsion and custom formulations with terpenes, such as limonene for anxiety or myrcene for sleep. Consumer preferences are shifting toward natural wellness products, particularly in urban centers like São Paulo and Rio de Janeiro, where demand for vegan, cruelty-free, and organic certification is increasing. Sustainability-conscious firms like HempMeds Brasil are exploring biodegradable packaging to attract ethical consumers. In Brazil, the demand for oils and tinctures is rising rapidly, especially in urban areas like São Paulo and Rio de Janeiro where wellness trends are increasingly popular. Many Brazilian consumers prefer the versatility of these products, which can be consumed directly or added to foods and drinks for a discreet and convenient way to experience the effects of cannabidiol. These oils are often marketed as natural solutions for anxiety, stress, and sleep disorders, with numerous local and international brands making their way into the market.

Capsules and softgels are another popular form in Brazil, particularly among individuals seeking precise and consistent dosages of CBD. Capsules are seen as a convenient and easy-to-use option, often marketed as a natural remedy for pain and inflammation. These products are especially popular among older consumers who are looking for simple ways to manage chronic conditions such as arthritis or insomnia. The market for gummies and confectionery is also growing in Brazil, especially among younger consumers who find them a fun and tasty way to incorporate CBD into their routines. These products are marketed as having potential benefits for relaxation, stress relief, and mood enhancement. As the beauty and personal care market in Brazil thrives, topicals and skincare products containing CBD are becoming increasingly popular.

Consumers in cities like São Paulo, Rio de Janeiro, and Curitiba are looking for CBD-infused lotions, creams, and serums for their anti-inflammatory and antioxidant properties. Lastly, vape products are seeing modest growth, especially in areas with more liberal views on cannabis use, but the legal restrictions around vaping and the public’s growing awareness of health risks associated with inhaling substances may limit this segment’s expansion in the long term.With growing awareness of the therapeutic benefits of CBD, more Brazilians are incorporating CBD into their daily wellness routines to help manage stress, anxiety, and sleep-related issues. Products like oils, tinctures, and capsules are popular among consumers seeking natural alternatives to pharmaceutical medications. The nutraceuticals and supplements is also experiencing significant growth in Brazil, with more consumers opting for CBD-infused dietary supplements to support their overall health. Brazil’s health-conscious population, particularly in major cities like São Paulo and Porto Alegre, has shown interest in CBD as a natural remedy for chronic pain, inflammation, and digestive issues. The pet care sector is emerging as an important part of the CBD market in Brazil.

Pet owners, especially in urban areas, are increasingly turning to CBD-infused products to help manage their pets’ anxiety, pain, and other health concerns. Brazilian pet stores are gradually introducing CBD oils and treats for animals, and demand is expected to grow as more consumers become aware of the potential benefits for their pets. Cosmetics and skincare are another rapidly growing sector in Brazil, as local and international beauty brands have started to offer CBD-infused products to cater to the country’s vast beauty market. Brazilian consumers are particularly interested in CBD’s potential to reduce inflammation and improve skin health, which has led to the rise of CBD creams, oils, and serums. The pharmaceuticals market in Brazil is also beginning to take notice of CBD, especially in the treatment of conditions such as epilepsy and chronic pain. Research institutions and healthcare providers in cities like São Paulo and Rio de Janeiro are conducting clinical studies on CBD’s potential therapeutic uses.

Finally, food and beverages containing CBD are slowly making their way into the Brazilian market. CBD-infused beverages, such as teas and coffees, are becoming increasingly popular among health-conscious consumers who are seeking functional, wellness-oriented drinks.In Brazil, marijuana-derived CBD is subject to stringent regulations, which limits its availability for commercial use. While medical cannabis use is legal under certain circumstances, the country’s regulatory framework surrounding marijuana-derived CBD remains highly controlled, with only a few licensed medical cannabis providers able to offer marijuana-based products. The Brazilian Health Regulatory Agency (ANVISA) has authorized specific products for medical use, particularly for conditions such as epilepsy and chronic pain, but the process remains complex and bureaucratic. As such, hemp-derived CBD is more commonly found in the Brazilian market. Hemp-based products are legal in Brazil as long as they do not contain THC levels exceeding 0.3%, aligning with international standards for hemp production.

Hemp-derived CBD products are often imported from countries where hemp farming is well-established, such as Canada, the United States, and European nations like the Netherlands and Switzerland. With the increasing demand for wellness and skincare products containing CBD, the hemp-derived CBD market is expected to expand rapidly. As of now, hemp farming is not yet a significant industry in Brazil, but there are discussions about the potential for domestic hemp cultivation in the future. Local companies are exploring opportunities to partner with international hemp producers, and there are increasing calls for more supportive regulations around hemp farming to allow for local production of cannabidiol. The regulatory landscape surrounding hemp in Brazil is still evolving, and there is significant potential for growth in this sector if the country moves toward a more progressive stance on hemp cultivation. Considered in this report• Historic Year: 2019• Base year: 2024• Estimated year: 2025• Forecast year: 2030Aspects covered in this report• Cannabidiol Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Form• Oils & Tinctures• Capsules & Softgels• Gummies & Confectionery• Topicals / Skin Care• Vape Products• OthersBy End Use• Wellness & Personal Use• Nutraceuticals & Supplements• Pet Care• Cosmetics & Skin Care• Pharmaceuticals• Food & BeveragesBy Source• Marijuana• Hemp.